FDA Introduces Regulatory Changes for Non-Animal Drug Testing Methods
The FDA has officially updated regulations to allow New Approach Methodologies (NAMs) for drug safety testing. This shift potentially accelerates drug development timelines while ensuring safety. It presents an opportunity for pharmaceutical contractors to adopt innovative testing methods to comply with newer standards.